Skip to main content
SpringerLink
Log in

Practical Application of Monoclonal Antibodies to Diagnostic Tumorpathology and Some Future Perspectives.

  • Chapter
Application of Monoclonal Antibodies in Tumor Pathology

Part of the book series: Developments in Oncology ((DION,volume 50))

Abstract

Accurate classification of malignant tumors is important in predicting the clinical course and in selecting therapeutic strategies. Although conventional light-microscopic examination of representative tumor tissue specimens often results in a definite diagnosis, in quite a number of cases only a differential diagnosis can be made. Then “special” techniques such as plastic embedding, electronmicroscopy, and immunocyto/histochemistry can be helpful.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kersey JH, LeBien TW, Abramson LS, Newman R, Sutherland R, Greaves M: P24: A human leukemin associated and lymphohemopoietic progenitor cell surface structure identification with monoclonal antibody. J Exp Med 153: 726–731, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Dvoretski Ph, Wood GS, Levy R, Warnke RA: T lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils. Human Pathology 13: 618–623, 1982.

    Article  Google Scholar 

  3. Brandtzaeg P: Tissue preparation methods for immunohistochemistry. In: Techniques in immunohistochemistry, Vol 1. Edited by GR Bullock and P Tetrus. Academic Press, London, New York, pp 1–75, 1985.

    Google Scholar 

  4. Polak JM, Van Noorden S: Immunocytochemistry. Practical applications in pathology and biology. Chapter 2, pp 11–42. Publ. John Wright 1 Sons Ltd. Stonebridge press, Bristol BS45MU, England, 1983.

    Google Scholar 

  5. Gatter KC, Alcock C, Heryet A, Pulford KA, Taylor-Papadimitriou J, Stein H, Mason DY. The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol 82: 33–43, 1984.

    PubMed  CAS  Google Scholar 

  6. Meijer CJLM, Willemze R, Henzen-Logmans SC, Van der Valk P: Monoclonal antibodies in the histopathological diagnosis of non- Hodgkin’s lymphomas. Neth J Med 38, 138–141, 1985.

    Google Scholar 

  7. Gown AM, Vogel AM: Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol 84: 413–424, 1985.

    PubMed  CAS  Google Scholar 

  8. Van Duinen SG, Ruiter DJ, Hageman Ph, Vennegoor C, Dickersin GR, Scheffer E, Rümke Ph: Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma. Cancer 53: 1566–1573, 1984.

    Article  PubMed  Google Scholar 

  9. Vennegoor C, Calafat J, Hageman Ph, Van Buitenen F, Janssen H, Kolk A, Rümke Ph: Biochemical characterization and cellular localization of a formalin resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C3. Int J Cancer 35: 287–295, 1985.

    Article  PubMed  CAS  Google Scholar 

  10. Natali PG, Imai K, Wilson BS, Bigotti A, Cavaliere R, Pellegrino MA, Ferrone S: Structural properties and time distribution of the antigen reorganized by the monoclonal antibody 653.40.S to human melanoma cells. J Natl Cancer Inst 67: 591–595, 1981.

    PubMed  CAS  Google Scholar 

  11. Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C: Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies. Cancer Immunol Immunother 7: 405–413, 1983.

    Google Scholar 

  12. Vennegoor C: Personal communication, 1986.

    Google Scholar 

  13. Ruiter DJ, Broecker EB, Vennegoor C, Ferrone S: Monoclonal antibodies recognizing melanoma associated antigens. Chapter 8 in this volume.

    Google Scholar 

  14. Roholl PJM, De Jong ASH, Ramaekers FCS. Application of markers in the diagnosis of soft tissue tumours. Histopathology 9, 1019–1035, 1985.

    Article  PubMed  CAS  Google Scholar 

  15. Osborn M, Dirk T, Käser H, Weber K, Altmannsberger M: Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma. Am J Pathol 122: 433–442, 1986

    PubMed  CAS  Google Scholar 

  16. Osborn M, Weber K: Tumor diagnosis by intermediate filament typing. Lab Invest 48: 372–394, 1983.

    PubMed  CAS  Google Scholar 

  17. Osborn M, Altmannsberger M, Shaw G, Schauer A, Weber K: Various sympathetic derived human tumors differ in neurofilament expression. Use in diagnosis of neuroblastoma, ganglio-neuroblastoma and pheochromocytoma. Virchows Arch B (Cell Path) 40: 141–156, 1982.

    Article  CAS  Google Scholar 

  18. De Ley L et al, Chapter 10 in this volume.

    Google Scholar 

  19. De Jong ASH, van Vark M, Albus-Lutter ChE, van Raamsdonk W, Voûte PA: Myosin and myoglobin as tumor markers in the diagnosis of rhabdomyosarcoma: a comparative study. Am J Surg Pathol 8: 512–528, 1984.

    Google Scholar 

  20. Sun TI, Eichner R, Schemer A, Cooper D, Nelson WG, Weiss RA: In: Cancer Cells 1, The transformed phenotype (Eds. AJ Levine, GF Vande Woude, WC Topp, JD Watson), Cold Spring Harbor Symp. Cold Spring Harbor, pp 169–176, 1984.

    Google Scholar 

  21. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelial tumors and cultures cells. Cell 31: 11–24, 1982

    Article  PubMed  CAS  Google Scholar 

  22. Moll R, Franke WW: Cytochemical cell typing of metastatic tumors according to their cytoskeletal proteins. In: Biochemistry and molecular genetics of cancer metastasis. K Lagris, LA Liobta and AS Rabion (eds). Martinus Nijhoff Publishing, Boston, Dordrecht, Lancaster, pp 101–113, 1986.

    Chapter  Google Scholar 

  23. Jasani B, Edwards RE, Thomas ND, Gibbs AR: The use of vimentin antibodies in the diagnosis of malignant mesotheliomas. Virchows Arch (Pathol Anat) 406: 444–448, 1985.

    Google Scholar 

  24. Mullink H, Henzen-Logmans SC, Alons-van Kordelaar JJM, Tadema TM, Meijer CJLM: Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis: malignant mesothelioma - pulmonary adenocarcinoma. Virchow’s Arch B (Cell Path), 1986 (in press).

    Google Scholar 

  25. Corson JM, Pinkus GS: Mesothelioma: profile of keratin proteins and CEA. An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinoma. Am J Pathol 108: 80–87, 1982.

    PubMed  CAS  Google Scholar 

  26. Gibbs AR, Harach NR, Wagner JC, Jasani B: Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax 40: 91–95, 1985.

    Article  PubMed  CAS  Google Scholar 

  27. Kwee WS, Veldhuizen RW, Golding RP, Mullink H, Stam J, Donner R, Boon ME: Histologic distinction between malignant mesotheliomas, benign pleural lesions and carcinoma metastasis. Virchows Arch A (Pathol Anat) 397: 287–299, 1982.

    Article  CAS  Google Scholar 

  28. Szpak CA, Johnston WW, Roggli V, Kolbeck J, Lottich C, Vollmer R, Thor A, Schlom J: The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3). Am J Pathol 122: 252–260, 1986.

    PubMed  CAS  Google Scholar 

  29. Schlingemann RO, Dingjan GM, Emeis JJ, Warnaar SO, Ruiter DJ: Monoclonal antibody PAL-E specific for endothelium. Lab Invest 52: 71–77, 1985.

    PubMed  CAS  Google Scholar 

  30. Donner L, de Lanerolle P, Costa J: Immunoreactivity of paraffin-embedded normal tissue and mesenchymal tumors for smooth muscle myosin. Am J Clin Pathol 80: 677–681, 1983.

    PubMed  CAS  Google Scholar 

  31. Herpers MJHM: Intermediate filament expression in human neuro- ectodermal brain tumors. Academic thesis, State University Limburg. Schrijen-Lippertz BV Voerendaal 1986.

    Google Scholar 

  32. Bonnin JR, Rubinstein LJ: Immunohistochemistry of central nervous system tumours. Its constitution to neurosurgical diagnosis. J Neurosurgery 60: 1121–1131, 1984.

    Article  CAS  Google Scholar 

  33. Isobe T, Ichimosi K, Nakajima T, Okuyema T. The alpha-subunit of S100 proteins present in tumor cells of human malignant melanomas, but not in schwannomas. Brain Res 294: 381–384, 1984.

    Article  PubMed  CAS  Google Scholar 

  34. Takahashi J, Isobe T, Ohtsuki Y, Akahji T, Sonobe H, Okuyama T: Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissue. Virchows Arch B (Cell Path) 45: 384–396, 1984.

    Google Scholar 

  35. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Reed-Sternberg cells of Hodgkin’s disease and a subset of normal lymphoid cells. Nature 294: 65–67, 1982.

    Article  Google Scholar 

  36. Poppema S, Brinker M, Buys CHCM, Timens W, Osinga J, Visser L: On the origin of Reed Sternberg cells. Immunoglobulin gene rearrangements in Hodgkin’s disease cell lines and in tissues from patients with Hodskin’s disease. Submitted for publication.

    Google Scholar 

  37. Hsu SM, Jaffe ES: LeuMl and peanut agglutinin stain the neoplastic cells of Hodgkin’s disease. Am J Pathol 82: 29–32

    Google Scholar 

  38. Jaffe ES, Strauchen JA, Berard CW: Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin’s lymphomas. Am J Clin Pathol 77: 46, 1982.

    PubMed  CAS  Google Scholar 

  39. Nathwani BN, Winberg CD: Non-Hodgkin’s lymphomas: an appraisal of the ‘working formulation of non-Hodgkin’s lymphomas for clinical usage’. In: Malignant lymphomas, Pathology Annual Monograph. Eds S Sommers and PP Rosen. Appleton-Century-Crofts, Norwalk, Connecticut, pp 1–63, 1983.

    Google Scholar 

  40. Stein H, Lennert K, Feller AC, Mason DY: Immunohistological analysis of human lymphoma: Correlation of histological and immunological categories. Adv Cancer Res 42: 67–147, 1984.

    Article  PubMed  CAS  Google Scholar 

  41. Meijer CJLM, Van der Valk P, Poppema S: Marker studies in lymphomas. In: Monographs in immunology. Eds W den Otter and E Ruitenberg. Elsevier, Amsterdam, 1986 (in press).

    Google Scholar 

  42. Van den Oord JJ, de Wolf-Peeters C, Frizzera G, Desmet VJ, Tricot G, Thomas J, Marien K, Gatter KC, Mason DY: T-helper cell lymphoma involving the lymph nodes and skin. A clinical, morphologic and immunohistochemical analysis of 5 cases. Cancer 55, 1714–1721, 1985.

    Article  PubMed  Google Scholar 

  43. Van der Valk P, Willemze, R, Meijer CJLM: Peripheral T cell lymphomas. A clinicopathological and immunologic study of 10 cases. Histopathology 10: 235–249, 1986.

    Article  PubMed  Google Scholar 

  44. Waldron JA, Leech JH, Glick AD, Flexner JM, Collins RD: Malignant lymphomas of periphernal T-lymphocyte orgin. Immunologic, pathologic and clinical features in 6 patients. Cancer 40, 1604–1617, 1977.

    Article  PubMed  CAS  Google Scholar 

  45. Watanabe S, Shimosato Y, Shimoyama M: Lymphoma and leukemia of T-lymphocytes. Pathology Annual 16, 155–203, 1981.

    PubMed  CAS  Google Scholar 

  46. Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H: Malignant lymphoma, intermediate lymphocytic type. A clinico- pathologic study of 42 cases. Cancer 48: 1415–1425, 1981.

    Article  PubMed  CAS  Google Scholar 

  47. Van der Valk P, Meijer CJLM: Histiocytic sarcoma. Path Annu (2) 1–14. Appleton-Century Croft, New Castle, Connecticut, 1985.

    Google Scholar 

  48. Dearnaley DP, Sloan JP, Ormerod MG et al: Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Brit J Cancer 44: 85–89, 1981.

    Article  PubMed  CAS  Google Scholar 

  49. Van Dongen JJM, Adriaansen HJ, Hooijkaas H: Immunological characterization of cells in the various hematopoietic differentiation stages and their malignant counterparts. Chapter 6 in this volume.

    Google Scholar 

  50. Fleuren GJ: Monoclonal antibodies against ovarian cancer. Chapter 13 in this volume.

    Google Scholar 

  51. Mattes MJ, Cordon-Cardo C, Lewis JL, Old JL, Lloyd KO: Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies. Proc Natl Acad Sci USA 81: 568–572, 1984.

    Article  PubMed  CAS  Google Scholar 

  52. Tsuji Y, Suzuki T, Nishiura H, Takemura T, Osojima S: Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies. Cancer Res 45: 2358–2362, 1985.

    PubMed  CAS  Google Scholar 

  53. Nap M, ten Hoor KA, Fleuren GJ: Cross reactivity with normal antigens in commercial anti CEA sera, used for immunohistology. The need for tissue controls and absorptions. Am J Clin Pathol 79: 25–31, 1983.

    PubMed  CAS  Google Scholar 

  54. Van der Linden JC, Baak JPA, Lindeman J, Smeulders AWM, Meijer CJLM: Carcinoembryonic antigen expression and peanut agglutinin binding in primary breast cancer and lymph node metastases; lack of correlation with clinical, histopathological, biochemical and morphometric features. Histopathology 9: 1051–1059, 1985.

    Article  PubMed  Google Scholar 

  55. Koprowsky H, Herlijn M, Steplewsky HH, Sears HF: Specific antigen in serum of patients with colon carcinoma. Science 212: 53–55, 1981.

    Article  Google Scholar 

  56. Bast RC, Feeney M, Lazarus H, Nadler LM: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331–1337, 1981.

    Article  PubMed  Google Scholar 

  57. Poels L, Peters O, Van Megen Y, Vooys GP, Verheyen R, Willemsen A, Van Niekerk C, Jap P, Mungyer G, Kenemans P: Monoclonal antibody against human ovarian tumor associated surface antigens. J Natl Cancer Inst.: in press, 1986.

    Google Scholar 

  58. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20, 1983.

    Article  PubMed  CAS  Google Scholar 

  59. Gerdes J, Lemke H, Batch H, Waeker H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715, 1984.

    PubMed  CAS  Google Scholar 

  60. Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson KSA, Antoniades HN: Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221: 275–277, 1983.

    Article  PubMed  CAS  Google Scholar 

  61. Kramer RH, Nicolson GL: Invasion of vascular endothelial cell monolayers and underlying matrix by metastatic human cancer cells. In Schweiger GH (ed): International Cell Biology, p 794, Berlin, Springer Verlag, 1981.

    Google Scholar 

  62. Rao CN, Margulies IMK, Tralka TS, Madri J, Liotta LA: Isolation of a subunit of laminin and its role in tumor cell attachment. J Biol Chem 257: 9740, 1982.

    PubMed  CAS  Google Scholar 

  63. Jalkanen ST, Butcher EC: In vitro analysis of the homing properties of human lymphocytes: Developmental regulation of functional receptors for high endothelial venules. Blood 66: 577–584, 1985.

    PubMed  CAS  Google Scholar 

  64. Pals ST, Kraal G, Horst E, Groot A de, Scheper RJ, Meijer CJLM: Human lymphocyte - high endothelial venule interactions: organ selective binding of T- and B-lymphocyte populations to high endothelium. J Immunol 1986 (in press).

    Google Scholar 

  65. Visser R, Van der Beek JMH, Havenith MG, Cleutjens JPM, Bosman FT: Immunocytochemical detection of basement membrane antigens in the histopathological evaluation of laryngeal dysplasia and neoplasia. Histopathology 10: 171–180, 1986.

    Article  PubMed  CAS  Google Scholar 

  66. Skipper HE, Simpson-Herren L: Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy. In: Important advances in oncology 1985, pp 63–77, eds VT de Vita, S Hellman, SA Rosenberg. JB Lippincot Company, Philadelphia, 1985.

    Google Scholar 

Download references

Authors
  1. C. J. L. M. Meijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Mullink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. C. Henzen-Logmans
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, University Medical Center, Nijmegen, The Netherlands

    Dirk J. Ruiter

  2. Department of Pathology, University Medical Center, Leiden, The Netherlands

    Gert Jan Fleuren  & Sven O. Warnaar  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Meijer, C.J.L.M., Mullink, H., Henzen-Logmans, S.C. (1987). Practical Application of Monoclonal Antibodies to Diagnostic Tumorpathology and Some Future Perspectives.. In: Ruiter, D.J., Fleuren, G.J., Warnaar, S.O. (eds) Application of Monoclonal Antibodies in Tumor Pathology. Developments in Oncology, vol 50. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3299-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3299-9_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7981-5

  • Online ISBN: 978-94-009-3299-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation